Research published in Scientific Reports identified a novel 12-amino acid peptide, VLGREEWSTSYW, that selectively binds to the cancer-specific receptor mutation EGFRvIII, commonly found in glioblastoma. Using phage display and molecular simulation, the study demonstrates that this peptide binds to a hydrophobic cavity on the receptor, offering a potential mechanism for targeted imaging and precision cancer therapies. For the full study, visit Scientific Reports (via ResearchGate) .
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to CMU | the music business explained.
Your link has expired.
Success! Check your email for magic link to sign-in.